Table 3 Univariate and multivariable analysis of prognostic indicators on overall survival and disease-free survival for metachronous metastatic colorectal cancer patients (N = 98)

0.691 (0.376–1.271)

0.235

0.678 (0.303–1.515)

0.343

0.829 (0.453–1.518)

0.544

0.990 (0.439–2.231)

0.980

0.933 (0.525–1.658)

0.933

0.848 (0.409–1.755)

0.656

1.018 (0.574–1.806)

0.951

0.912 (0.433–1.921)

0.808

0.824 (0.454–1.495)

0.523

0.985 (0.449–2.164)

0.971

0.764 (0.421–1.388)

0.378

1.033 (0.477–2.237)

0.935

0.897 (0.490–1.643)

0.725

1.088 (0.512–2.310)

0.826

0.896 (0.489–1.641)

0.722

1.043 (0.471–2.311)

0.917

0.972 (0.412–2.295)

0.949

0.699 (0.238–2.050)

0.514

1.047 (0.443–2.473)

0.917

1.030 (0.356–2.980)

0.956

1.062 (0.588–1.923)

0.844

0.989 (0.448–2.181)

0.570

1.090 (0.604–1.965)

0.776

0.813 (0.364–1.817)

0.614

605 (0.216–1.695)

0.339

0.628 (0.126–3.128)

0.766

0.625 (0.223–1.7448)

0.370

1.044 (0.210–5.200)

0.958

1.062 (0.586–1.923)

0.844

1.090 (0.604–1.965)

0.776

1.643 (0.921–2.932)

0.093

1.160 (0.519–2.629)

0.707

1.555 (0.869–2.782)

0.137

1.297 (0.549–3.068)

0.553

1.411 (0.785–2.536)

0.250

1.107 (0.470–2.611)

0.816

1.312 (0.731–2.354)

0.363

0.933 (0.369–2.361)

0.884

0.991 (0.530–1.851)

0.977

0.680 (0.289–1.603)

0.378

1.147 (0.616–2.134)

0.666

0.901 (0.377–2.154)

0.815

1.432 (0.763–2.688)

0.264

1.414 (0.561–3.562)

0.462

1,479 (0.788–2.779)

0.223

1.187 (0.454–3.101)

0.727

3.577 (1.464–8.741)

0.005

3.090 (1.130–8.445)

0.028

4.609 (1.864–11.396)

0.001

4.012 (1.477–10.900)

0.006

1.249 (0.690–2.260)

0.462

1.815 (0.823–4.004)

0.140

1.066 (0.597–1.904)

0.829

1.440 (0.656–.081)

0.260